Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) just unveiled an announcement.
Rapid Dose Therapeutics Corp. (RDT) has expanded its collaboration with an unnamed international company to advance the development of QuickStrip® Nicotine products, targeted for a 2025 market launch. This strategic partnership emphasizes RDT’s commitment to pioneering science-based, smoke-free alternatives, leveraging their unique Oral Thin Film (OTF) technology to meet global market demands and transition adult smokers to safer options.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp. (RDT) is a Canadian biotechnology company known for its proprietary QuickStrip™ delivery system. The company focuses on developing innovative oral nicotine products and delivering breakthrough innovations aimed at promoting a smoke-free future.
YTD Price Performance: -6.82%
Average Trading Volume: 43,631
Technical Sentiment Consensus Rating: Hold
Current Market Cap: C$25.55M
See more data about DOSE stock on TipRanks’ Stock Analysis page.